MedPath

Diaphragm Response in Elderly for Acute Monitoring

Not yet recruiting
Conditions
Acute Dyspnea
Acute Respiratory Failure
Diaphragmatic Ultrasound
Registration Number
NCT07132268
Lead Sponsor
Centre Hospitalier de Bethune
Brief Summary

Acute dyspnea is a common cause of emergency department admissions among elderly patients. Acute respiratory failure is often multifactorial and requires rapid and reliable evaluation. Currently, management relies on clinical, biological, and radiological assessments, but diaphragmatic ultrasound could provide an additional tool for real-time respiratory function evaluation. This study aims to integrate this non-invasive technology into the initial assessment of patients to improve care pathways. Hypothesis : Diaphragmatic ultrasound enables reliable assessment of respiratory function and can predict the need for mechanical ventilation.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
145
Inclusion Criteria
  • Patients aged ≥ 75 years
  • Emergency admission for acute dyspnea
  • Requiring an emergency ultrsoung.
Exclusion Criteria
  • Acute respiratory distress requiring immediate invasive or non-invasive ventilation
  • Respiratory rate ≥ 25 breaths/min, and/or SpO2 ≤ 90% on room air, and/or PaO2 ≤ 60 mmHg
  • Known diaphragmatic paralysis
  • Patients with degenerative neuromuscular disease
  • State of shock: systolic blood pressure < 90 mmHg and/or mean arterial pressure < 65 mmHg and/or presence of skin mottling and/or CTR > 3s
  • Lactate levels > 2 mmol/L
  • Hypercapnic respiratory acidosis (pH < 7.38 and PaCO2 > 45 mmHg)
  • Dyspnea due to metabolic acidosis (e.g., diabetic ketoacidosis, renal failure)
  • Dyspnea of traumatic origin
  • Refusal to participate or inability to provide informed consent
  • Patients deprived of liberty
  • Patients under guardianship or curatorship

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Occurrence of a severe acute respiratory event within 7 days of admissionWITHIN 7 DAYS OF ADMISSION

* Placement on invasive mechanical ventilation (intubation) or non invasive ventilation (NIV, high-flow oxygen therapy),

* Respiratory death, confirmed by an independent adjudication committee blinded to the ultrasound results.

Explanatory variable: The presence of impaired diaphragmatic function at admission will be defined by:

* a Tdi (tele-inspiratory thickness) \<10%, and/or

* a diaphragmatic excursion \<10 mm.

Secondary Outcome Measures
NameTimeMethod
Measurement of diaphragmatic excursion AND Etiology of acute dyspneawithin 7 days

To study the association between diaphragmatic excursion curve parameters (EDR, inspiratory time, expiratory time, etc.) and the etiology of acute dyspnea in patients aged 75 years and older admitted for acute dyspnea

To evaluate the contribution of diaphragmatic ultrasound to the NEWS2 score performed on admission in predicting the occurrence of acute respiratory distress within 7 days.within 7 days

The discriminatory power of the NEWS2 score in predicting the occurrence of acute respiratory distress, the discriminatory power of the NEWS2 score combined with impaired diaphragmatic function on admission ultrasound.

NEWS 2 : The higher the score, the greater the risk of clinical deterioration. 0-4 : low risk Score of 3 in any individual parameter : low-medium 5-6 : moderate risk

\> or = 7 : high risk

Trial Locations

Locations (9)

Centre Hospitalier Victor Dupouy

🇫🇷

Argenteuil, France

Centre Hospitalier de Béthune

🇫🇷

Béthune, France

Centre Hospitalier de Douai

🇫🇷

Douai, France

Centre Hospitalier Emile Roux

🇫🇷

Le Puy-en-Velay, France

Centre Hospitalier Sud Ile-de-France

🇫🇷

Melun, France

Centre Hospitalier de Roubaix

🇫🇷

Roubaix, France

Centre Hospitalier de Saint-Lô

🇫🇷

Saint-Lô, France

Centre Hospitalier de Tourcoing

🇫🇷

Tourcoing, France

Centre Hospitalier de Valenciennes

🇫🇷

Valenciennes, France

Centre Hospitalier Victor Dupouy
🇫🇷Argenteuil, France
Catherine LE GALL, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.